Eliquis 5 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26F88GW
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,509
Award facts
- Contract value 100% obligated
- $12,508.86 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count) valued at $12,508.86 on December 18, 2025, with an ultimate completion date of December 19, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation. The award is structured as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $1 billion and extending through December 2026. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement across military and veteran healthcare systems.
The delivery order represents a single transaction within AmerisourceBergen's comprehensive pharmaceutical supply arrangement with DLA, which enables the company to provide a broad range of medications, vaccines, and medical supplies to support military healthcare programs globally. Eliquis is an anticoagulant medication used in military and federal health systems for stroke prevention and treatment of blood clots. AmerisourceBergen's contract portfolio with DLA demonstrates consistent capability to meet federal procurement requirements through open competition, with delivery orders ranging substantially in value and encompassing diverse therapeutic domains including diabetes, neurological, and pain management medications.
Quick answers
Who was awarded contract SPE2DR26F88GW?
SPE2DR26F88GW was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 18, 2025.
How much is contract SPE2DR26F88GW worth?
The government has obligated $12,509 on SPE2DR26F88GW.
Is contract SPE2DR26F88GW an order under another contract?
Yes. SPE2DR26F88GW is a delivery order under SPE2DR25D3010, an indefinite delivery contract.
Was contract SPE2DR26F88GW competed?
The extent of competition for SPE2DR26F88GW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award